Open menu

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

Endomagnetics Completes Acquisition of the ACT Portfolio

Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, announced today the acquisition of the ACT portfolio and related assets from Actium Biosystems, LLC. This move extends Endomagnetics' oncology platform from diagnostics into therapeutics while maintaining synergies with its magnetic nanoparticle technology.

Posted: Jun 24th, 2014

Read more

BIND Therapeutics and Roche Collaborate on Discovery of Novel Nanomedicines

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.

Posted: Jun 19th, 2014

Read more

Avidity NanoMedicines Announces Issuance of Two Landmark Patents for Antibody-siRNA Complex Technology

Avidity NanoMedicines, a biopharmaceutical company pioneering development of the Antibody-siRNA Complex (ARC) as a new therapeutic class, announced the issuance of two new U.S. patents. ARCs combine the potency and specificity of biologics with a nucleic acid-based payload, representing a breakthrough approach to the targeted delivery of nucleic acid-based medicines.

Posted: Jun 18th, 2014

Read more

OCSiAl Acquires Zyvex Technologies

OCSiAl, a leading technology manufacturer for the mass industrial production of graphene tubes, announced today at a press conference at the TechConnect World Innovation Conference that it has acquired Zyvex Technologies.

Posted: Jun 16th, 2014

Read more